Research use only · Multi-region fulfillment · Support-assisted ordering
VestaResearch Supply
Duratia 30mg Tablets | 100-Count | DAPOXETINE
Performance & Hormone OptimizationPharma

Duratia 30mg Tablets | 100-Count | DAPOXETINE

$110

In stock

For in vitro laboratory research only. Not for human or veterinary consumption.

India Warehouse DAPOXETINE — 30mg per tablet, 100-count pack. Short-acting SSRI specifically for premature ejaculation (PE) — taken on-demand 1–3 hours before sexual activity. Approved in Europe and Asia; not approved in USA. Key warning: Orthostatic hypotension/syncope risk especially with alcohol. MAOIs contraindicated. Hepatic impairment contraindication. Avoid potent CYP3A4 inhibitors.

SKU
VES-000525-DURATIA-30MG-100TAB
Format
N/A
Use
Laboratory research only
Ask on Telegram

What is Duratia 30mg (DAPOXETINE)?

Short-acting SSRI specifically for premature ejaculation (PE) — taken on-demand 1–3 hours before sexual activity. Approved in Europe and Asia; not approved in USA.

How it Works

Rapid-onset, short-acting SSRI — inhibits serotonin reuptake, increasing synaptic serotonin and delaying ejaculatory reflex. Rapid absorption and elimination make it suitable for on-demand use.

Quick Specs

Form
Oral tablets — pre-dosed
Active Ingredient
DAPOXETINE
Dose per Tablet
30MG
Pack Size
10×10 (100 tablets)
Storage
Room temperature (15–25°C), cool dry place
Shelf Life
2–3 years (properly stored)

Common Side Effects

Nausea (most common), dizziness, headache, diarrhea, insomnia. Syncope (rare) — take seated or lying down initially.

Safety Warnings

Orthostatic hypotension/syncope risk especially with alcohol. MAOIs contraindicated. Hepatic impairment contraindication. Avoid potent CYP3A4 inhibitors. International shipping: 7–14 days

Research use only

This material is supplied strictly for in vitro laboratory research. It is not intended for human or veterinary consumption, diagnosis, treatment, or household use.